Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nayanta Sodha

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature Reviews. Cancer|November 16, 2007
CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin?Laurent Antoni, Nayanta Sodha, Ian Collins, et al.
Cancer Research|September 20, 2006
Rare germ line CHEK2 variants identified in breast cancer families encode proteins that show impaired activationNayanta Sodha, Tine S Mantoni, Sean V Tavtigian, et al.
Human Mutation|January 17, 2002
A robust method for detecting CHK2/RAD53 mutations in genomic DNANayanta Sodha, Richard S Houlston, Richard Williams, et al.
Cancer Letters|October 19, 2004
Analysis of familial male breast cancer for germline mutations in CHEK2Nayanta Sodha, Charlotte Wilson, Sarah L Bullock, et al.
Human Mutation|November 21, 2002
Increasing evidence that germline mutations in CHEK2 do not cause Li-Fraumeni syndromeNayanta Sodha, Richard S Houlston, Sarah Bullock, et al.
Cancer Research|October 30, 2003
Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotypeMagali Olivier, David E Goldgar, Nayanta Sodha, et al.
Cancer Letters|June 17, 2006
BRCA1/BRCA2 mutation status and analysis of cancer family history in participants of the Royal Marsden Hospital tamoxifen chemoprevention trialZsofia Kote-Jarai, Trevor J Powles, Gillian Mitchell, et al.
Histopathology|December 17, 2009
Overexpression of RAD51 occurs in aggressive prostatic cancerAnita Mitra, Charles Jameson, Yolanda Barbachano, et al.
Molecular Cancer Therapeutics|May 8, 2007
p53 therapy in a patient with Li-Fraumeni syndromeNeil Senzer, John Nemunaitis, Michael Nemunaitis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2009
Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS StudyD Gareth R Evans, Fiona Lennard, Linda J Pointon, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Reviews. Cancer|November 16, 2007
CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin?Laurent Antoni, Nayanta Sodha, Ian Collins, et al.
Cancer Research|September 20, 2006
Rare germ line CHEK2 variants identified in breast cancer families encode proteins that show impaired activationNayanta Sodha, Tine S Mantoni, Sean V Tavtigian, et al.
Human Mutation|January 17, 2002
A robust method for detecting CHK2/RAD53 mutations in genomic DNANayanta Sodha, Richard S Houlston, Richard Williams, et al.
Cancer Letters|October 19, 2004
Analysis of familial male breast cancer for germline mutations in CHEK2Nayanta Sodha, Charlotte Wilson, Sarah L Bullock, et al.
Human Mutation|November 21, 2002
Increasing evidence that germline mutations in CHEK2 do not cause Li-Fraumeni syndromeNayanta Sodha, Richard S Houlston, Sarah Bullock, et al.
Cancer Research|October 30, 2003
Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotypeMagali Olivier, David E Goldgar, Nayanta Sodha, et al.
Cancer Letters|June 17, 2006
BRCA1/BRCA2 mutation status and analysis of cancer family history in participants of the Royal Marsden Hospital tamoxifen chemoprevention trialZsofia Kote-Jarai, Trevor J Powles, Gillian Mitchell, et al.
Histopathology|December 17, 2009
Overexpression of RAD51 occurs in aggressive prostatic cancerAnita Mitra, Charles Jameson, Yolanda Barbachano, et al.
Molecular Cancer Therapeutics|May 8, 2007
p53 therapy in a patient with Li-Fraumeni syndromeNeil Senzer, John Nemunaitis, Michael Nemunaitis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2009
Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS StudyD Gareth R Evans, Fiona Lennard, Linda J Pointon, et al.
Pageof 2